SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roger Cranwill who wrote (1302)10/7/1997 11:58:00 PM
From: contrarian   of 1762
 
Roger,

Thanks for the info on production. I recall that there are some 130,000+ target patients. I assume that this number was used to define 98 earning projections. Looks like everything is on track.

On a personal note, one of my best friends actually took this drug as part of the FDA trials in early 96. He was getting tumors every nine months for 13 straight years. The turmors were non-cancerous and this was his last resort since he could no longer receive radiation or chemotheropy. We just celibrated his 2 year anniversary with no turmors. This story is why I got involved in IDEC.

Good Luck and Thanks Again,

Contrarian
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News